Surface representation of wild-type SARS-CoV-2 and glycosylated RBDM1 and RBDM2 shown as green and other coloured spheres using the FoldX algorithm.

Saved in:

Bibliographic Details
Main Author:	Zuxin Liang (16414112) (author)
Other Authors:	Chunhui Li (501186) (author), Xiaohua Gong (261560) (author), Guoguo Ye (9707977) (author), Yushan Jiang (16414109) (author), Huiping Shi (3135015) (author), Abid Hussain (375044) (author), Mengyuan Zhao (412470) (author), Mengjun Li (4750566) (author), Yuxin Tian (442502) (author), Wei Zhao (14321) (author), Yang Yang (45629) (author), Yuanyu Huang (1422829) (author), Chenguang Shen (11560967) (author), Minghui Yang (588064) (author)
Published:	2024
Subjects:	Biophysics Microbiology Molecular Biology Evolutionary Biology Immunology Infectious Diseases Virology Computational Biology xlink "> emerging receptor binding domain providing valuable insights mediated immune responses elicit antibodies capable antibody binding changes spectrum neutralizing efficacy engineered glycosylation modifications conserved antibody response 2 rbd vaccines neutralizing sars wide range type rbd thereby exposing targeted approach related coronaviruses prone sites mice challenged messenger rna decisive factor coronaviruses remain conferred protection cellular immunity 2 variants 16 strain
Tags:	Add Tag No Tags, Be the first to tag this record!

Surface representation of wild-type SARS-CoV-2 and glycosylated RBD<sup>M1</sup> and RBD<sup>M2</sup> shown as green and other coloured spheres using the FoldX algorithm.